Haven't used Pinscriptive, Inc. yet?
Ask AI

Ask AI about Pinscriptive, Inc.

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Steven Turnwall
Reviews 1

Pinscriptive, Inc. has been a valuable partner in our business journey. Their expertise and dedication have helped us achieve great success. The team is knowledgeable, professional, and always goes the extra mile to ensure our satisfaction. Highly recommended!

Anthony Wilson
Reviews 1

We have been fortunate to work with Pinscriptive, Inc. for our business needs. Their expertise and commitment have helped us achieve incredible success. The team is knowledgeable, professional, and always meets deadlines. We highly recommend their services.

John Somers
Reviews 1

Pinscriptive, Inc. provides excellent services with incredible attention to detail. Their team is highly skilled and professional. They truly understand our needs and deliver outstanding results. We are thrilled to be working with them.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="pinscriptive-com" data-lang="en"></div>
More widgets

About Pinscriptive, Inc.

Specialty drugs account for 2% of all drugs sold, but by 2018 will be 50% of the spend for drugs. Pinscriptive uses advanced big-data analytics and collaborative approaches to identify the right drugs, for the right patient at the right time, therefore reducing cost and improving outcomes. In essence, Pinscriptive will deliver evidence backed, value-based decision support for at-risk providers and payers seeking to make the most appropriate specialty drug decision.

There is currently estimated to be up to $20billion in annual, solvable specialty Rx inefficiencies in the US alone. By identifying which drugs are most effective for which patients (precision analytics for precision medicine) Pinscriptive can significantly reduce costs for providers and payers. The business model also seeks to be collaborative with biopharma, as they too will face pay-for-performance pressures via risk-based contracting.